Sugar-Coated Nanoparticles Revolutionize Personalized Medicine

Strategic Insights -

Research from Jamia Hamdard in New Delhi, India, has unveiled the potential of sugar-coated nanoparticles (SCNPs) to transform healthcare by delivering targeted drug therapy with enhanced efficacy and reduced toxicity. These nanoparticles, designed to interact with glycan molecules, have shown promise in treating multifactorial diseases such as cancer, tuberculosis, and neurodegenerative disorders. The study highlights the advancements in SCNP applications, including maltose-functionalized dendrimers and glycodendrimersomes, which have demonstrated potential in overcoming challenges like multidrug resistance and achieving pH-responsive drug release.

Key Takeaways:

  • SCNPs leverage glycan interactions to achieve superior therapeutic efficacy and reduced systemic toxicity.
  • Functionalized with sugars like mannose, dextran, and maltose, SCNPs address multifactorial diseases, including cancer, tuberculosis, and neurodegenerative disorders.
  • Recent developments in SCNP applications include maltose-functionalized dendrimers and glycodendrimersomes, offering multivalent targeting and self-assembly properties.
  • Clinical and preclinical studies have demonstrated the efficacy of glycan-functionalized nanoparticles in delivering drugs with improved bioavailability and targeted cellular uptake.
  • SCNPs have shown potential in crossing the blood-brain barrier and targeting liver cancer, offering new possibilities for personalized medicine.
  • The study emphasizes the importance of integrating AI-driven design and sustainable synthesis methods to optimize SCNPs for personalized medicine.

Statistics:

  • 2025: The year in which the research on sugar-coated nanoparticles was published.
  • 125752: The reference number of the research article published in the International Journal of Pharmaceutics.
  • 679: The volume number of the International Journal of Pharmaceutics where the research article was published.
  • 29: The number of Radarweg in Amsterdam, Netherlands, where Elsevier, the publisher of the Journal, is located.
  • 1043 Nx: The postal code in Amsterdam, Netherlands, where Elsevier is located.
  • 2025 JUN 9: The date on which the news report was published in Nanotechnology Weekly.

Sources:

  • VerticalNews
  • Jamia Hamdard
  • VerticalNews correspondents
  • International Journal of Pharmaceutics (Elsevier - www.elsevier.com; International Journal of Pharmaceutics - www.journals.elsevier.com/international-journal-of-pharmaceutics/)
  • Anchal Salmani
  • Shadma Wahab
  • Taghreed Majrashi
  • Garima Gupta
  • Khang Wen Goh
  • Prashant Kesharwani
  • Urushi Rehman, Dept. of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi 110062, India.